Fred Hutch Cancer Center shared a post on LinkedIn:
“Dr. Shailender Bhatia has been named the inaugural holder of the Lyn and Daniel Lerner Endowed Chair in Merkel Cell Carcinoma at Fred Hutch.
This endowed chair, made possible by the Lerner family in honor of their father, will fuel groundbreaking research into one of the most aggressive forms of skin cancer.
Dr. Bhatia has dedicated his career to improving outcomes for Merkel cell carcinoma patients, leading pioneering immunotherapy trials that have transformed treatment options. With this new support, he’ll continue pushing the boundaries of care and mentoring the next generation of MCC researchers.
More from Fred Hutch Cancer Center on OncoDaily.